55687-33-7

Usage

Uses

Used in Pharmaceutical Industry:
2-Chloro-6-fluoroquinoxaline is used as a key intermediate in the synthesis of quinoxaline-based compounds, which have potential applications as antidotes for acetanilide herbicides. These antidotes can help counteract the toxic effects of these herbicides, providing a valuable solution for agricultural and environmental purposes.
Additionally, quinoxaline derivatives have been found to possess a range of biological activities, including antimicrobial, antiviral, and anticancer properties. As a result, 2-chloro-6-fluoroquinoxaline can be utilized in the development of new drugs and therapeutic agents for various medical applications.

InChI:InChI=1/C8H4ClFN2/c9-8-4-11-7-3-5(10)1-2-6(7)12-8/h1-4H

Upstream product

• 924-44-7 glyoxylic acid ethyl ester 
• 367-31-7 4-fluoro-1,2-phenylenediamine 
• 145323-53-1 7-fluoro-1,2-dihydroquinoxalin-2-one 
• 55687-23-5 6-fluoroquinoxalin-2(1H)-one 
• 148010-65-5 6-fluoro-1,2,3,4-tetrahydroquinoxalin-2-one 
• 55687-24-6 N-(5-fluoro-2-nitrophenyl)glycine ethyl ester 
• 446-35-5 2,4-Difluoronitrobenzene 

Downstream Products

• 112080-06-5 2,6-Difluoro-quinoxaline 
• 21335-55-7 n-pentenyl alcohol 
• 76578-80-8 6-fluoro-2-(4-hydroxyphenoxy)-quinoxaline 
• 1621366-64-0 N-(3,4-difluorophenyl)-5-[(6-fluoroquinoxalin-2-yl)amino]-3-methyl-1,2-thiazole-4-carboxamide 
• 1621366-38-8 N-(2-ethylphenyl)-5-[(6-fluoroquinoxalin-2-yl)amino]-3-methyl-1,2-thiazole-4-carboxamide 

Relevant academic research and scientific papers

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C Virus Inhibitors

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

The present invention relates to compounds of formula wherein Ar, Het, R1 and n are as defined herein and to pharmaceutically suitable acid addition salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. Compounds of formula I are orexin receptor antagonists and are useful in the treatment of sleep apnea, narcolepsy, insomnia, parasomnia, jet lag syndrome, circadian rhythms disorder and sleep disorders associated with neurological diseases.

Carbamic acid ester herbicides

Carbamic acid ester compounds of the formula STR1 wherein A represents the group (a) or (b) STR2 wherein R1 -R8, X and Y are as defined hereinafter, processes for their preparation, herbicidal compositions containing these compounds and methods for the use of the compounds and the herbicidal compositions are disclosed.

A FACILE SYNTHESIS OF NOVEL TRICYCLIC COMPOUNDS, TETRAZOLOQUINOXALINES AND 1,2,4-TRIAZOLOQUINOXALINES

Novel 5-methyltetrazoloquinoxalin-4-ones (5) and 5-methyl-1,2,4-triazoloquinoxalin-4-ones (7) could be synthesized from 1-methyl-3-chloroquinoxalin-2-ones (3) and 1-methyl-3-hydrazinoquinoxalin-2-ones (6), respectively.Further extensive study was carried out to synthesize 4- or 7- substituted and 4,7-disubstituted tetrazoloquinoxalines (10) and 1,2,4-triazoloquinoxalines (12).